Memantine and Changes of Biological Markers and Brain PET Imaging in Alzheimer’s Disease
Condition(s):Alzheimer’s DiseaseLast Updated:December 3, 2010Completed
Hide Studies Not Open or Pending
Condition(s):Alzheimer’s DiseaseLast Updated:December 3, 2010Completed
Condition(s):Autism Spectrum Disorder (ASD); Autism; Autistic Disorder; Asperger’s Disorder; Asperger’s; Pediatric Autism; Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS)Last Updated:August 7, 2014Completed
Condition(s):ADHD; Executive Function Deficits (EFD’s)Last Updated:September 24, 2013Withdrawn
Condition(s):AOD Effects and ConsequencesLast Updated:October 3, 2017Unknown status
Condition(s):Autism Spectrum DisordersLast Updated:March 24, 2016Completed
Condition(s):Neuropathic PainLast Updated:February 4, 2019Unknown status
Condition(s):Autism Spectrum Disorder (ASD); Autism; Autistic Disorder; Asperger’s Disorder; Asperger’s; Pediatric Autism; Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS)Last Updated:February 16, 2015Terminated
Condition(s):Bioequivalence, AUC, Cmax, PharmacokineticsLast Updated:October 29, 2018Completed
Condition(s):Bipolar DisorderLast Updated:October 3, 2019Unknown status
Condition(s):KleptomaniaLast Updated:May 24, 2021Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.